These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12055083)

  • 1. Oxidative stress inactivates the human DNA mismatch repair system.
    Chang CL; Marra G; Chauhan DP; Ha HT; Chang DK; Ricciardiello L; Randolph A; Carethers JM; Boland CR
    Am J Physiol Cell Physiol; 2002 Jul; 283(1):C148-54. PubMed ID: 12055083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
    Yeh CC; Lee C; Dahiya R
    Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
    Yeh CC; Lee C; Huang MC; Dahiya R
    Mol Carcinog; 2001 Jul; 31(3):145-51. PubMed ID: 11479923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha.
    Plotz G; Raedle J; Brieger A; Trojan J; Zeuzem S
    Nucleic Acids Res; 2003 Jun; 31(12):3217-26. PubMed ID: 12799449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair and microsatellite instability in esophageal cancer cells.
    Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
    Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
    Hatch SB; Lightfoot HM; Garwacki CP; Moore DT; Calvo BF; Woosley JT; Sciarrotta J; Funkhouser WK; Farber RA
    Clin Cancer Res; 2005 Mar; 11(6):2180-7. PubMed ID: 15788665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations within the hMLH1 and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha.
    Räschle M; Dufner P; Marra G; Jiricny J
    J Biol Chem; 2002 Jun; 277(24):21810-20. PubMed ID: 11948175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of DNA mismatch repair proteins with human exonuclease I.
    Schmutte C; Sadoff MM; Shim KS; Acharya S; Fishel R
    J Biol Chem; 2001 Aug; 276(35):33011-8. PubMed ID: 11427529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
    Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
    Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC.
    Korhonen MK; Raevaara TE; Lohi H; Nyström M
    Oncol Rep; 2007 Feb; 17(2):351-4. PubMed ID: 17203173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
    Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
    Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
    Morimoto H; Tsukada J; Kominato Y; Tanaka Y
    Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation.
    Plaschke J; Krüger S; Pistorius S; Theissig F; Saeger HD; Schackert HK
    Int J Cancer; 2002 Feb; 97(5):643-8. PubMed ID: 11807791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
    Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
    Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.